SEARCH RESULTS FOR:
Jeff Olsen
CEO, BOART LONGYEAR
"Technology applied to our services business means geologists can cut out mundane tasks like logging core, in order to spend more time understanding the orebody. That is more attractive to everybody and it opens up a very diverse workforce."
Jeff Butler
PRESIDENT, AMPAC FINE CHEMICALS
"AFC’s core technology differentiators include energetic chemistry, high potency manufacturing, and extensive chromatographic separation capabilities."
Tyrone Brewer
PRESIDENT, US ONCOLOGY, JANSSEN PHARMACEUTICAL COMPANIES OF JOHNSON & JOHNSON
"I am excited about Janssen’s aspirational vision to eliminate cancer. With targeted therapies and immunotherapies, cancer treatment can be more effective and less toxic, enabling individuals to manage their disease while also maintaining their quality of life."
Joe Panetta
PRESIDENT AND CEO, BIOCOM CALIFORNIA
"The lifecycle of new product introduction into the market will now be shorter, as companies have fewer years to recover revenue as a result of the IRA."
Alan Driscoll
VP, DIRECTOR OF MINING SERVICES, FORSGREN ASSOCIATES
"The changing regulatory environment, pressure to streamline the permitting process, and significant investment coming into the state are all driving real-time planning, creative strategies, and good organization."
Joseph Kemp
VICE PRESIDENT AND GENERAL MANAGER - BALD MOUNTAIN, KINROSS GOLD CORPORATION
"Interestingly, despite increasingly challenging operating environments, the industry’s ounce production continues to maintain or improve. That speaks to the creativeness and technical expertise of the whole value chain of the industry."
Andrea Confetti & Roberto Fanelli
EXCLUSIVE SYNTHESIS BUSINESS UNIT LEADER (AC) & CATALOGUE APIS BU DEPUTY MANAGER (RF), DIPHARMA FRANCIS
RF: "Our experience in developing proprietary chemical processes and alternative solutions to support the generic API industry has been instrumental in rapidly expanding our CDMO activities."
United States Life Sciences 2023 - Digital Interactive
In many ways, 2022 was a turning point for the US life sciences industry. After having provided a lightning-quick response to the Covid-19 pandemic, the industry gathered the lessons learned and sought a sense of normalcy to continue developing necessary drugs for patients worldwide. Yet, the geopolitical, macroeconomic, and regulatory environments all come with their set of challenges, forcing executives into increasingly complex decisions when defining their strategies.
Peru Mining 2023 Pre-Release II
This second pre-release edition of GBR's PERUMIN 2023 Official Investment Guide comprises an analysis based on more than 70 interviews with the leading executives from the entire mining value chain of the Peruvian mining industry to provide a holistic view of the events taking place in the country, how those events have impacted their activities, and what they expect for the upcoming months.
Daniel Palmacci
PRESIDENT, CELL & GENE DIVISION, LONZA
"We want to give patients the best access to the amazing technology and treatments being developed by cell and gene therapy innovators. This is the modality with the greatest potential in the healthcare industry today."
MACIG
SPANISH
SUBSCRIBE TO OUR NEWSLETTER
RECENT PUBLICATIONS
Peru Mining 2025 Pre-Release II
Featuring insights from nearly 120 mining executives, the second pre-release edition of GBR's Peru Mining 2025 sheds light on the industry's current state while highlighting Peru’s window of opportunity to align with the global energy transition and copper’s increasingly critical role.
Featuring insights from nearly 120 mining executives, the second pre-release edition of GBR's Peru Mining 2025 sheds light on the industry's current state while highlighting Peru’s window of opportunity to align with the global energy transition and copper’s increasingly critical role.
PARTNER EVENTS
SUBSCRIBE TO OUR
NEWSLETTER
- Get GBR content delivered to your inbox
- Receive industry based news
- Completely free, e-mail only
